SABBY 13G EMBI 7.31.20

Company

Skye Bioscience, Inc.

Filed

July 31, 2020

Accession Number

0001535610-20-000109

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →